Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial. [electronic resource]
Producer: 20190603Description: 146-156 p. digitalISSN:- 1479-9731
- Adult
- Aftercare
- Asthma -- epidemiology
- Behavior Therapy -- methods
- Combined Modality Therapy
- Community-Acquired Infections -- epidemiology
- Comorbidity
- Disease Progression
- Female
- Hospitalization
- Humans
- Inpatients
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Motivational Interviewing
- Odds Ratio
- Patient Preference
- Pneumonia -- epidemiology
- Prospective Studies
- Pulmonary Disease, Chronic Obstructive -- epidemiology
- Quality of Life
- Referral and Consultation
- Smoking -- epidemiology
- Smoking Cessation -- methods
- Smoking Cessation Agents -- therapeutic use
- Varenicline -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.